67877-675 : Deferasirox Oral Oral 90 mg Oral Granule
NDC: | 67877-675 |
Labeler: | Ascend Laboratories, LLC |
Product Type: | Human Prescription Drug |
Drug Name: | Deferasirox Oral |
Dosage Form: | Oral Granule |
Application #: | ANDA213374 |
Rev. Date: |
NDC Package Codes:
- 67877-675-84: 30 PACKET IN 1 CARTON (67877‑675‑84) > 1 GRANULE IN 1 PACKET (67877‑675‑71)
Active Ingredients:
- Deferasirox
Dosage Strength:
- 90 mg
Pharmaceutical Classes:
- Iron Chelating Activity [MoA]
- Iron Chelator [EPC]
- Cytochrome P450 3A4 Inducers [MoA]
- Cytochrome P450 2C8 Inhibitors [MoA]
- Cytochrome P450 1A2 Inhibitors [MoA]
Related Products:
Based on records with the same trade name.- 67877-676 Deferasirox Oral Oral 180 mg Oral Granule by Ascend Laboratories, LLC
- 67877-677 Deferasirox Oral Oral 360 mg Oral Granule by Ascend Laboratories, LLC
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 67877-674Next: 67877-676 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.